Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous adipose stem cells to assist skin grafting
ChiCTR2000037456Phase 3Not yet recruiting
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Oct 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of autologous adipose-derived mesenchymal stromal cells in soft tissue defect (2 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Skin elasticity of grafted skin (primary) at 6 months. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
soft tissue defect
Beyond the preview
Go deeper on ChiCTR2000037456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037456.